AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Dovalue

Investor Presentation May 15, 2025

4145_rns_2025-05-15_ea6c469c-943e-4562-9159-33cb27e94d57.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

MAY 15TH, 2025

Q1 2025 Financial Results

  • GBV €9.2 from new business in 2025 YTD surpassing the €8 billion full-year target
  • Strong growth in Gross Revenues reaching €141m and EBITDA ex NRI up triple digit (+106% YoY)
  • Leverage decreasing to 2.3x2 despite seasonality and on track to reach 2.0x by the end of the year
  • Non-NPL revenues up to 39% of Gross Revenues, on track to reach 40-45% target by 2026
  • Strong cash conversion with significant improvement (+€48m YoY in FCF)

UPDATED TARGET FOR NEW BUSINESS FOR THE CURRENT YEAR €12+ BILLION GBV AND 2025 GUIDANCE CONFIRMED

Executive summary

EBITDA ex NRIs €51m

New Business €9.2bn

Financial Leverage 2.3x

Free Cash flow €32m

Non-NPL Revenues 39%

emarket
sdir storage
CERTIFIED

Business plan projections based on a stable macro environment Deterioration could generate up to €30bn in additional GBV inflows, with controlled impact on collections

Economic downturn as a tailwind for GBV with impact on collections under control

Sources: 1. EUROSTAT, Business registration and bankruptcy index by NACE Rev.2 activity – seasonally adjusted quarterly data, May 2025; 2. CRIBIS, Report CRIBIS Fallimenti delle imprese 2024, April 2025 and 3. Report CRIBIS Fallimenti delle imprese Q1 2025, April 2025; 4. Cerved, Osservatorio procedure e liquidazioni, March 2025; 5. Solunion, April 2025; 6. Creditreform, May 2025;

Business Resilience in a Deteriorating Macroeconomic Scenario

  • EU
  • Seasonally adjusted bankruptcies remain near multi-year highs, up ~60% from 2021 levels, despite a minor QoQ dip in Q4 2024
  • In Q4 2024, declarations were above 2019 levels across all sectors1

Italy

  • Filed judicial liquidations grew +19.7% YoY in 2024, nearing pre-COVID highs
  • The stock of companies in judicial liquidation in Q4 2024 grew by +32.3% YoY (+70% vs 2022)2
  • In Q1 2025, judicial liquidations rose by +11.3% YoY3
  • Business insolvencies surged by +17.2% YoY in 2024 (+9.8% YoY in 2023)4

Spain

  • Business insolvencies up +17.5% YoY in 2024 and +5.2% YoY in Q1 2025
  • March 2025 showed a slight decline (-9% MoM), yet trend remains upward5

Greece

• +42.5% YoY increase in bankruptcies in 2024 due to new legal frameworks. Highest growth in Western Europe6

Cyprus

• +399.3% YoY in Q4 2024 in bankruptcy declarations1

Upward trend of bankruptcies poses an opportunity for GBV inflows

  • The portfolio is largely composed of secured loans, REOs and positions in advanced or judicial stages, which are less sensitive to macro conditions
  • Legal processes and recovery strategies already underway reduce exposure to worsening borrower fundamentals
  • A deteriorating environment is expected to accelerate NPL formation, expanding the servicing opportunity pipeline across all NPE spectrum
  • Our infrastructure and expertise position us to capitalize on the next wave of NPL portfolios entering the market
  • ~90% of AuM with vintage >5 years and >85% AuM in judicial proceeding stage or REO, both isolating collections performance from fluctuations of the macro environment

GBV FROM NEW BUSINESS IN 2025 YTD

GBV from new business surpassing 2025 target YTD

Strong commercial momentum: new mandates at €8.1 billion in Q1 2025, exceeding the €6bn annual target in the first three months of the year

Forward Flows at €1.1 billion, on track to reach annual target of €2bn

On top of transactions already announced:

  • New NPL mandates in Spain from a leading banking institution for c.€300m, expanding the scope of products we service for them
  • New mandates include €0.9bn from smaller/single tickets transactions

Thanks to the strong start of the year, we are Increasing 2025 target of new business to €12+ billion GBV

18-month pipeline expanded thanks to our diversification strategy

• 18-month pipeline includes ~€47bn GBV, net of the GBV already assigned YTD

Non-Financial Receivables significantly expanding our addressable market as the investment in the diversification strategy and digital platform pays off

• Tangible prospects in Spain, with NPE deals primarily from banking clients

doValue expanded its pipeline significantly through the entrance in the non financial receivables space (i.e. Tax Receivables, Telcos, Utilities) thanks to the successful implementation of the diversification strategy outlined in the business plan and the launch of the digital platform

All main diversification activities targeted in 2024 either completed or started

monetization

emarket
sdir scorage
CERTIFIED

Gardant Integration Update

Gardant integration progressing well and remains on track to deliver planned synergies

Titolo breaker slide Financial Results Davide Soffietti Group CFO

Financials at a glance

∆%
YoY

Strong double-digit growth in gross revenues vs. prior year

Revenues up YoY even excluding Gardant contribution

VAS revenues more than doubled YoY continuing the positive
momentum seen in the past quarters

Higher net revenues driven by a contained impact of
consolidation on outsourcing costs which decreased as % of
gross revenues by c.2%
vs. Q1 2024

EBITDA more than doubled vs prior year

EBITDA up double digit even excluding Gardant contribution

Increase in costs linked to Gardant's cost base mitigated by
initial synergies

Strong improvement in EBITDA margin YoY despite the low
seasonality quarter thanks to the accretive impact of Gardant

Increase in Net Income ex NRIs thanks to the positive trend in
EBITDA ex NRIs and despite higher financial interest and
minorities

Gross Revenues (€m) COMMENTS

Gross Revenues

Group

  • Gross revenues up +46% YoY, supported by Gardant contribution, initial synergies, as well as continued strong contribution of Value Added Services
  • Gross revenues grew also on a stand-alone basis
  • Non-NPL revenues in Q1 2025 amounted to 39% of gross revenues
  • Outsourcing costs as % of gross revenues decreased YoY at 9.3% vs. 11.1% in Q1 2024

Hellenic Region

  • Revenues up 8% YoY mainly driven by UTP and Value Added Services
  • NPL revenues were also up YoY in the first quarter

Italy

  • Overall revenues up +111% YoY, driven by Gardant contribution
  • Very positive trends also on a standalone basis with double digit growth driven by UTP and Value Added Services

Spain

• Revenues only slightly down by €(0.7) million YoY due to declining REOs mitigated by improvement in all other categories

Operating Expenses

Total Operating expenses

• Successfully contained the natural increase in operating costs from the consolidation of Gardant thanks to continued cost discipline across functions

HR

  • Higher HR cost (+27.7% YoY) linked to the effect of Gardant consolidation and to the increase in variable compensation following better-than-expected performance of the business
  • HR costs increased in Greece due to the onboarding of new large portfolios

Operating Expenses ex NRIs (€m) COMMENTS

IT, RE and SG&A

• Operating costs increased only by €2.4 million YoY thanks to initial synergies that were able to successfully mitigate the effect of Gardant's consolidation

EBITDA ex NRIs

Group

  • EBITDA ex NRIs reached €51m in Q1 2025 more than twice the EBITDA of Q1 2024
  • Variation mainly driven by the increase of Italy and by strong performance of UTP and VAS driving revenues
  • EBITDA margin increased significantly thanks to the accretive impact of Gardant

Hellenic Region

  • Hellenic EBITDA increased 7.7% driven by positive trends in UTPs and VAS
  • EBITDA margin of 44.7% continues to drive group margins (36.4% Group level) despite some onboarding costs of new portfolios in Greece

Italy

  • EBITDA up €24.1 million thanks to Gardant as well as to positive contribution of UTP and VAS to Gross Revenues
  • Effective cost discipline measures and initial synergies mitigated the impact of the consolidation of Gardant's cost base

Spain

• Slightly negative EBITDA in a low seasonality quarter, with lower cost base and on track to deliver positive EBITDA at year-end

NRIs limited to €(0.5) million with EBITDA reported at €50.9 million

Note: Q1 2025 EBITDA includes group costs in Italy worth €3.1m. In Q1 2024 figures Portugal is included in non recurring items due to its sale in July 2024

Net Income

€m Q1
2025
Q1
2024
Delta
EBITDA ex NRIs 51.4 25.0 26.5
Non-Recurring Items (0.5) 0.0 (0.5)
EBITDA 50.9 24.9 26.0
Net write-down of PP&E, intangibles, loans and
equity investments
(20.7) (19.0) (1.8)
EBIT 30.2 5.9 24.2
Net financial interest and commission (20.1) (7.4) (12.7)
Net result of financial assets at fair value 0.9 0.4 0.5
EBT 10.9 (1.1) 12.0
Income tax (5.9) (4.7) (1.2)
Minorities (6.0) (1.3) (4.7)
Group Net Income reported (0.9) (7.1) 6.1
Non Recurring
Items
(10.1) (4.6) (5.5)
Group Net Income ex NRIs 9.1 (2.4) 11.6
Delta COMMENTS

Higher EBITDA ex NRIs driven by positive momentum across
products and markets

Write-downs on PP&E, intangibles, loans and equity investments
in line with collection curves

Higher financial interest and commission driven by the impact of
the new bond (€2.8
million interest and amortized costs), the new
term loan (€7.7 million interest and amortized costs), and the
residual interest on the 2026 SSN (€1.3 million). The line also
includes €7.3 million one-off costs related to the refinancing of the
2026 bond.

Income tax for the period increased on the back of a higher
EBITDA as well as the consolidation of Gardant's profit-making
(4.7) legal entities

Minorities increased due to Gardant's partnerships with Banco
BPM and BPER
ctly prohibited
emarket
sdir storage
CERTIFIED

Cash Flow

€m Q1 2025 Q1 2024 Delta (€m)
EBITDA 50.9 24.9 26.0
Capex (2.2) (1.8) (0.4)
Change in NWC and accruals on
share-based payments
11.5 (11.3) 22.7
IFRS 16 (6.0) (6.9) 0.9
Redundancies (2.4) (4.2) 1.8
Other changes in other assets &
liabilities
(4.3) 3.3 (7.6)
Cash Flow from Operations 47.3 3.9 43.4
Taxes (7.0) (9.1) 2.1
Financial charges (8.9) (11.6) 2.7
Free Cash Flow 31.5 (16.7) 48.2
Investments in equity & financial
assets
(12.1) (24.7) 12.6
Cash flow before dividend &
financial debt
19.4 (41.4) 60.8

  • Cash flow from operations, equal to €47.3m, in 2024, +€43.4 million higher than LY (€3.9m) with a much higher cash conversion reaching 93% from 16% in Q1 2024
    • Moderate increase in Capex (+€0.4m YoY), mainly driven by Gardant
    • Remarkable reduction in NWC (+€22.7m YoY) thanks to improving control of invoicing cycle with SPVs and positive advance payments dynamics
    • Lease payments slightly decreased compared to prior year despite Gardant's offices and thanks to real estate efficiencies carried out throughout 2024. More will be realized over 2025
    • Redundancies at €2.4 million in Q1 2025, €1.8 million lower than Q1 24
    • Other changes in other assets and liabilities mainly related to payments from provisioned funds
  • Free cash flow of €31.5 million, up by a remarkable €48.2 million YoY driven by the higher CFO which more than offset the increase in financial charges related to the final interest payment and early redemption of the 2026 senior secured loan and interest on the new term loan
  • Equity & financial assets investments equal to €(12.1)m mainly related to the payment of the earnout for doValue Greece, as well as financial assets

COMMENTS

Financial Structure

COMMENTS
(2)

Net
leverage
at
2.3x
,
continuing
its
deleverage
path
towards
FY
guidance
(2.0x)
even
including
the
extraordinary
cash
out
of
€11
million
earn-out
related
to
doValue
Greece
paid
in
Q1
Other liabilities
Solid
liquidity
buffer
of
€273m,
including
€130m
undrawn
RCF
lines
(o/w
€80m
3-year
facilities)
TL
(2)
Maturity 10/2029

Stable
corporate
rating
(BB/Stable
Outlook),
confirmed
amidst
deteriorated
credit
profiles
of
debt
purchasers
and
servicers,
praising
our
asset-light
business
model
SSN
Maturity 02/2030
7.000% coupon (2)

Our
bond
trades
at
one
of
the
lowest
yields
in
the
sector,
with
a
YTM
~6%,
mirroring
lower
perceived
credit
risk
and
investor
confidence

Average
cost
of
debt
at
6.64%

Cash on BS

Notes: (1) Pro forma including Gardant (2) Including accrued interests and fin. Assets measured at amortized cost (3) Pro forma including the collection by doValue Spain of an Earn Out of

€22.7 million occurred in April 2024, as illustrated in Q1 2024 results release

Solid deleverage path supported by strong improvement in cash flow dynamic on track to reach net leverage expectations on organic basis

emarket
sdir storage
CERTIFIED

2025 Guidance confirmed

Note: (1) Free cash flow after interest, to serve dividend and principal repayment (2) Leverage target before dividend payment

Positive cash generation will support further deleverage by 2026

Increasing the guidance on the back of strong new business dynamics

+€12bn new business in 2025 as target was raised on the back of strong new business YTD

• Includes synergies in line with business plan (€5m in 2025 and €15m in 2026)

2025
Gross revenues €600-615m
Gross Book Value €135-140bn
EBITDA ex NRIs €210-220m
FCF(1) €60-70m assumptions:
Financial leverage 2.0x(2)

COMMENTS

Free cash flow to serve dividend and principal repayment. Includes the following

  • higher use of DTAs becoming available in 2025

  • interest expenses of €45m in 2025

  • €5m extraordinary capex in 2025 for IT synergies linked to Gardant

  • €10-15m exit costs in 2025-26 primarily linked to Gardant synergies

  • €11m earn-out for doValue Greece in 2025 paid in Q1 2025

Non-NPL revenues to ~ 40-45% in 2026 from 39% in Q1 2025

2026 business plan targets confirmed

Titolo breaker slide Appendix

Regional Performance

Notes: EBITDA for Italy excluding Group costs worth €3.1m

Hellenic
Region
Italy Spain
€141bn €43bn €87bn €11bn
€1.1bn €0.4bn €0.5bn €0.2bn
4.3% 5.4% 3.3% 8.9%
€141m €52m €78m €11m
€51m €23m €32m €(0.8)m
36.4% 44.7% 41.0% (6.7)%

emarket
sdir scorage
CERTIFIED

Very positive GBV dynamics in the first quarter

Improvement in GBV dynamic: natural GBV reduction being offset by solid inflows from existing clients and strong new business

Inflows from new clients: intakes by region worth €1.9bn from Italy, €6.6bn from the Hellenic Region, mainly NPLs, and €0.7bn from Spain

emarket
sdir storage
CERTIFIED

Condensed Income Statement

Condensed Income Statement 3/31/2025 3/31/2024 Change € Change %
NPL Servicing revenues 85,603 64,685 20,918 32.3%
Non
-NPL Servicing revenues
24,672 19,231 5,441 28.3%
Value added services 31,161 15,126 16,035 106.0%
Gross revenues 141,436 99,042 42,394 42.8%
NPE Outsourcing fees (4,901) (2,923) (1,978) 67.7%
REO Outsourcing fees (1,836) (2,351) 515 (21.9)%
Value added services Outsourcing fees (6,452) (6,000) (452) 7.5%
Net revenues 128,247 87,768 40,479 46.1%
Staff expenses (59,890) (47,865) (12,025) 25.1%
Administrative expenses (17,477) (14,986) (2,491) 16.6%
o.w. IT (7,520) (6,200) (1,320) 21.3%
o.w. Real Estate (1,942) (1,150) (792) 68.9%
o.w. SG&A (8,015) (7,636) (379) 5.0%
Operating expenses (77,367) (62,851) (14,516) 23.1%
EBITDA 50,880 24,917 25,963 104.2%
EBITDA margin 36.0% 25.2% 10.8% 43.0%
Non
-recurring items included in EBITDA
(540) (35) (505) n.s.
EBITDA excluding non
-recurring items
51,420 24,952 26,468 106.1%
EBITDA margin excluding non
-recurring items
36.4% 25.7% 10.7% 41.5%
Net write
-downs on property, plant, equipment and intangibles
(18,191) (13,673) (4,518) 33.0%
Net provisions for risks and charges (2,503) (5,300) 2,797 (52.8)%
Net write
-downs of loans
(34) 2 (36) n.s.
EBIT 30,152 5,946 24,206 n.s.
Net income (loss) on financial assets and liabilities measured at fair value 893 362 531 146.7%
Net financial interest and commissions (20,099) (7,393) (12,706) n.s.
EBT 10,946 (1,085) 12,031 n.s.
Non
-recurring items included in EBT
(10,470) (4,656) (5,814) 124.9%
EBT excluding non
-recurring items
21,417 3,571 17,846 n.s.
Income tax (5,896) (4,721) (1,175) 24.9%
Profit (Loss) for the period 5,050 (5,806) 10,856 n.s.
Profit (loss) for the period attributable to Non
-controlling interests
(5,996) (1,251) (4,745) n.s.
Profit (Loss) for the period attributable to the Shareholders of the Parent Company (946) (7,057) 6,111 (86.6)%
Non
-recurring items included in Profit (loss) for the period
(10,088) (4,641) (5,447) 117.4%
O.w. Non
-recurring items included in Profit (loss) for the period attributable to Non
-controlling interest
(12) (18) 6 (33.3)%
Profit (loss) for the period attributable to the Shareholders of the Parent Company excluding non
-recurring items
9,130 (2,434) 11,564 n.s.
Profit (loss) for the period attributable to Non
-controlling interests excluding non
-recurring items
6,008 1,269 4,739 n.s.
Earnings per share (in Euro) (0.005) (0.455) 0.450 (98.9)%
Earnings per share excluding non
-recurring items (Euro)
0.048 (0.157) 0.205 (130.7)%

Earnings per share excluding non

Condensed Balance Sheet

-

-

-

-

-

-

-

-

-

-

Condensed Balance Sheet 3/31/2025 12/31/2024 Change € Change %
Cash and liquid securities 142,961 232,169 (89,208) (38.4)%
Financial assets 49,001 49,293 (292) (0.6)%
Equity investments 12 12 - n.s.
Property, plant and equipment 52,703 52,305 398 0.8%
Intangible assets 679,028 682,684 (3,656) (0.5)%
Tax assets 101,385 105,200 (3,815) (3.6)%
Trade receivables 225,682 263,961 (38,279) (14.5)%
Assets held for sale 10 10 - n.s.
Other assets 77,233 64,231 13,002 20.2%
Total Assets 1,328,015 1,449,865 (121,850) (8.4)%
Financial liabilities: due to banks/bondholders 643,025 733,419 (90,394) (12.3)%
Other financial liabilities 70,623 76,675 (6,052) (7.9)%
Trade payables 86,611 110,738 (24,127) (21.8)%
Tax liabilities 109,276 108,989 287 0.3%
Employee termination benefits 11,658 11,913 (255) (2.1)%
Provisions for risks and charges 21,472 23,034 (1,562) (6.8)%
Other liabilities 68,547 73,046 (4,499) (6.2)%
Total Liabilities 1,011,212 1,137,814 (126,602) (11.1)%
Share capital 68,614 68,614 - n.s.
Share premium 128,800 128,800 - n.s.
Reserves 14,139 12,493 1,646 13.2%
Treasury shares (9,348) (9,348) - n.s.
Profit (loss) for the period attributable to the Shareholders of the Parent Company (946) 1,900 (2,846) (149.8)%
Net Equity attributable to the Shareholders of the Parent Company 201,259 202,459 (1,200) (0.6)%
Total Liabilities and Net Equity attributable to the Shareholders of the Parent Company 1,212,471 1,340,273 (127,802) (9.5)%
Net Equity attributable to Non
-Controlling Interests
115,544 109,592 5,952 5.4%
Total Liabilities and Net Equity 1,328,015 1,449,865 (121,850) (8.4)%

emarket
sdir storage
CERTIFIED

Condensed Cash Flow

Condensed Cash flow 3/31/2025 3/31/2024 12/31/2024
EBITDA 50,880 24,917 154,045
Capex (2,248) (1,816) (23,769)
EBITDA-Capex 48,632 23,101 130,276
as % of EBITDA 96% 93% 85%
Adjustment for accrual on share
-based incentive system payments
618 (1,061) 1,176
Changes in Net Working Capital (NWC) 10,843 (10,205) (5,895)
Changes in other assets/liabilities (12,752) (7,896) (41,885)
Operating Cash Flow 47,341 3,939 83,672
Corporate Income Tax paid (6,954) (9,060) (25,656)
Financial charges (8,873) (11,598) (29,777)
Free Cash Flow 31,514 (16,719) 28,239
(Investments)/divestments in financial assets 1,355 1,440 2,848
Equity (investments)/divestments (2,637) (373) (196,800)
Tax claim payment (10,800) (22,300) 400
Treasury shares buy
-back
- (3,421) (3,421)
Transaction costs - - (13,114)
Right Issue - - 143,138
Cash Flow before dividends and financial debt repayment 19,432 (41,373) (38,710)
Financial Debt repayment (9,122) - -
Net Cash Flow of the period 10,310 (41,373) (38,710)
Net financial Position
-
Beginning of period
(514,364) (475,654) (475,654)
Net financial Position
-
End of period
(504,054) (517,027) (514,364)
Change in Net Financial Position 10,310 (41,373) (38,710)
Adjustment for accrual on share
Treasury shares buy
-back
Transaction costs -
Right Issue -
Financial Debt repayment (9,122)
Net financial Position
Net financial Position
emarket
sdir storage
CERTIFIED

Glossary

Agreement with commercial bank related to the management of all future NPL generation by the bank for number of years, customary feature of credit servicing platforms spun off by

Full Time Equivalent, i.e. a unit that indicates the workload of an employed person in a way that makes workloads comparable across various contexts

Garanzia Cartolarizzazione Sofferenze, i.e. the State Guarantee scheme put together by the Italian Government in 2016 which favoured the creation of a more liquid NPL market in Italy

Gross Book Value, i.e. nominal value of assets under management by doValue, represents the maximum / nominal claim by banks / investors to borrowers on their portfolios

Early Arrears Loans that are up to 90 days past due
Forward Flows commercial banks
FTE Full Time Equivalent, i.e. a unit that indicates the workload of an employed person in a way that makes workloads comparable across various contexts
GACS and allowed banks to more easily deconsolidate NPL portfolios through securitisations
GBV
HAPS Greece and to allow banks to more easily deconsolidate NPL portfolios through securitisations
NPE Non-Performing Exposure, i.e. the aggregate od NPL, UTP and Early Arrears
NPL Non-Performing Loan, i.e. loans which are more than 180 days past due and have been denounced
NRI Non-Recurring Items, i.e. costs or revenues which are non-recurring by nature (typically encountered in M&A or refinancing transactions)
Performing Loans Loans which do not present problematic features in terms of principal / interest repayment by borrowers
REO Real Estate Owned, i.e. real estate assets owned by a bank / investor as part of a repossession act
Stage 2 Loans Subperforming
loans –
albeit not NP -
that have seen a significant increase in credit risk, resulting in "investment grade" credit quality
UTP Unlikely to Pay, i.e. loans that are between 90-180 days past due and denounced or more than 180 past due and not denounced

Hercules Asset Protection Scheme, i.e. the State Guarantee scheme put together by the Greek Government in 2019 with the aim of favouring the creation of a more liquid NPL market in

ctly prohibited
emarket
sdir storage
CERTIFIED

This presentation is not a prospectus and not an offer of securities for sale to U.S. persons or in any jurisdiction, including in or into the United States, Canada, Japan or Australia.

This disclaimer applies to all documents and information provided herein and to any verbal or written comments of person presenting them by doValue S.pA. and its affiliates ("doValue"). or any person on behalf of doValue, and any question and answer session that follows the oral presentation (collectively, the "Information"). in accessing the Information, you agree to be bound by the following terms and conditions. The Information may not be reproduces redistributed, published or passed on to any other person, directly or indirectly, in whole or In part, for any purpose.

This presentation and any materials distributed in connection herewith, taken together with any such verbal or written comments, including the contents thereof and the Information (together, the "Presentation") is not intended for potential investors and do not constitute or form a part of, and should not be construed as, an offer for sale or subscription of or solicitation of any offer to purchase or subscribe any securities, and neither this Presentation nor anything contained herein shall form the basis of, or be relied upon in connection with, or act as an inducement to enter into, any contract or commitment whatsoever. Any such offer would only be made by means of formal offering documents, the terms of which shall govern in all respects.

You are cautioned against using this information as the basis for making a decision to purchase any security or to otherwise engage in an investment advisory relationship with doValue S.p.A. and its affiliates. The distribution of this Presentation in other jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restriction. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdiction.

This Presentation has been prepared based on the information currently available to us and is based on certain key underlying assumptions. The information contained in this Presentation has not been independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, reasonableness or correctness of the information or opinions contained herein. None of doValue its subsidiaries or any of their respective employees, advisers, representatives or affiliates shall have any liability whatsoever (in negligence or otherwise) for any loss however arising from any use of this document or its contents or otherwise arising in connection with this Presentation. The information contained in this Presentation is provided as at the date of this Presentation and is subject to change without notice.

Statements made in this Presentation may include forward-looking statements. These statements may be identified by the fact that they use words such as "anticipate", "estimate", "should", "expect", "guidance", "project", "intend", "plan", "believe", and/or other words and terms of similar meaning in connection with, among other things, any discussion of results of operations, financial condition, liquidity, prospects, growth, strategies or developments in the industry in which we operate. Such statements, including specifically any guidance or projection, are based on management's current intentions, expectations or beliefs and involve inherent risks, assumptions and uncertainties, including factors that could delay, divert or change any of them.

Forward-looking statements contained in this Presentation and, in particular, in any relevant guidance, regarding trends or current activities are not guarantees of future performance and are subject to risks, uncertainties, and assumptions that are difficult to predict because they relate to events and depend on circumstances that may may/will occur in the future therefore should not be taken as a representation that such trends or activities will continue in the future. Actual outcomes, results and other future events may differ materially from those expressed or implied by the statements and guidance contained herein. Such differences may adversely affect the outcome and financial effects of the plans and events described herein and may result from, among other things, changes in economic, business, competitive, technological, strategic or regulatory factors and other factors affecting the business and operations of the company. Estimated and assumptions are inherently uncertain and are subject to risks that are outside of the company's control. Any guidance and statement refers to events and depend upon circumstances that may or may not verify in the future and refer only as of the date hereof. Therefore the Company's actual results may differ materially and adversely from those expressed or implied in any forward-looking statements. Neither doValue S.p.A. nor any of its affiliates is under any obligation, and each such entity expressly disclaims any such obligation, to update, revise or amend any forward-looking statements, whether as a result of new information, future events or otherwise.

You should not place undue reliance on any such forward-looking statements and or guidance, which speak only as of the date of this Presentation. The inclusion of the projections herein should not be regarded as an indication that the doValue considers the latter to be a reliable prediction of future events and the projections should not be relied upon as such. Use of different methods for preparing, calculating or presenting information may lead to different results and such differences may be material. It should be noted that past performance is not a guide to future performance. Please also note that interim results are not necessarily indicative of full-year results.

By reviewing the Presentation, you acknowledge that you are knowledgeable and experienced with respect to its financial and business aspects and that you will conduct your own independent investigations with respect to the accuracy, completeness and suitability of the matters referred to in the Presentation should you choose to use or rely on it, at your own risk, for any purpose.

No representation, warranty or undertaking, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the Information or the opinions contained therein.

The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to the Information, including any financial data or forward-looking statements, and will not publicly release any revisions it may make to the Information that may result from any change in the Company's expectations, any change in events, conditions or circumstances on which these forward-looking statements are based, or other events or circumstances arising after the date of this document. Market data used in the Information not attributed to a specific source are estimates of the Company and have not been independently verified.

Davide Soffietti, in his position as manager responsible for the preparation of financial reports, certifies pursuant to paragraph 2, article 154-bis of the Legislative Decree n. 58/1998, that data and accounting information disclosures herewith set forth correspond to the company's evidence and accounting books and entries.

Disclaimer

Daniele Della Seta Head of Group M&A, Strategic Finance and Investor Relations [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.